Cimetidine for a 6-Month-Old with GERD

Age-Appropriate Treatment Algorithm

The American Academy of Pediatrics recommends beginning with lifestyle modifications, including smaller, more frequent feedings, thickening formula, trial of maternal exclusion diet if breastfeeding, and positioning changes, for a 6-month-old patient with GERD 1
Famotidine 1 mg/kg/day divided in 2 doses is the preferred H2-receptor antagonist, as it is FDA-approved for children as young as 1 month and is 20-50 times more potent than cimetidine, with a strength of evidence level of high 1, 2

The American College of Gastroenterology recommends proton pump inhibitors, such as omeprazole 0.7-3.3 mg/kg/day, for symptom relief and healing erosive esophagitis in pediatric patients, but FDA approval is only for children ≥2 years, with a strength of evidence level of moderate 1, 4
Cimetidine has significant limitations, including antiandrogenic activity, interference with cytochrome P-450 metabolism, and lower potency compared to famotidine, with a strength of evidence level of low 2, 3

All H2-receptor antagonists develop tachyphylaxis within 6 weeks of continuous use, limiting their long-term effectiveness, with a strength of evidence level of high 1, 2
H2-receptor antagonists may increase the risk of community-acquired pneumonia, gastroenteritis, and candidemia in pediatric patients, with a strength of evidence level of moderate 1

Long-term PPI use carries risks of lower respiratory tract infections, particularly in infants, with a strength of evidence level of low 1